Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Leukemia, Myeloid, Chronic-Phase
Item
subjects with chronic phase chronic myeloid leukemia (cml)
boolean
C0023474 (UMLS CUI [1])
Imatinib Resistance | Intolerance to imatinib
Item
subjects resistant/intolerant to imatinib
boolean
C0935989 (UMLS CUI [1,1])
C1514892 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0935989 (UMLS CUI [2,2])
Subject Presenting
Item
subjects presenting:
boolean
C0681850 (UMLS CUI [1,1])
C0449450 (UMLS CUI [1,2])
ECOG performance status
Item
1. ecog performance status (ps) score 0-2
boolean
C1520224 (UMLS CUI [1])
Liver function
Item
2. adequate hepatic function
boolean
C0232741 (UMLS CUI [1])
Renal function
Item
3. adequate renal function
boolean
C0232804 (UMLS CUI [1])
Pulmonary function
Item
4. adequate lung function
boolean
C0231921 (UMLS CUI [1])
Cancer Other
Item
concurrent malignancy other than cml
boolean
C1707251 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
women who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Pleural effusion
Item
concurrent pleural effusion
boolean
C0032227 (UMLS CUI [1])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease
Item
uncontrolled or significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2])
Disease Uncontrolled Investigational Therapy Impaired
Item
a serious uncontrolled medical disorder that would impair the ability of the subjects to receive protocol therapy.
boolean
C0012634 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0949266 (UMLS CUI [1,3])
C0221099 (UMLS CUI [1,4])
dasatinib
Item
prior therapy with dasatinib
boolean
C1455147 (UMLS CUI [1])
BCR-ABL T315I mutation | Other Coding
Item
subjects with t315i and/or f317l bcr-abl point mutations
boolean
C3888919 (UMLS CUI [1])
C3846158 (UMLS CUI [2])